MHC
NVO

May Hill Capital’s Novo Nordisk NVO Stock Holding History

May Hill Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$697K Buy
+14,529
New +$624K 0.15% 102
2026
Q1 		– Sell
-12,106
Closed -$616K – 232
2025
Q4 		$616K Buy
12,106
+3,702
+44% +$189K 0.17% 88
2025
Q3 		$466K Sell
8,404
-279
-3% -$16.3K 0.14% 107
2025
Q2 		$599K Sell
8,683
-70
-0.8% -$4.76K 0.2% 83
2025
Q1 		$608K Buy
8,753
+3,883
+80% +$321K 0.23% 69
2024
Q4 		$419K Buy
+4,870
New +$527K 0.16% 83

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

May Hill Capital's NVO Position: Q2 2026 in Review

May Hill Capital opened a new position in Novo Nordisk (NVO) in Q2 2026: 14,529 shares worth $697K. The stake represents 0.15% of the portfolio and ranks #102 among its holdings. This is a return to the name: May Hill Capital previously reported a position in NVO as recently as Q4 2025.

May Hill Capital first reported a position in NVO in Q4 2024 and has held it in 6 quarters since. 1,355 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • May Hill Capital held 14,529 shares of Novo Nordisk worth $697K as of Q2 2026.
  • Novo Nordisk was a new May Hill Capital position in Q2 2026.
  • Novo Nordisk made up 0.15% of May Hill Capital's portfolio in Q2 2026, its #102 holding.
  • May Hill Capital first reported a position in Novo Nordisk in Q4 2024 and has held it in 6 quarters since.
  • 1,355 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on May Hill Capital's 13F filing for Q2 2026, filed 7 Aug 2026.